Heartflow, Inc.
(Incorporated in Delaware) We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess coronary artery disease (CAD) in more than […]
July 18, 2025 Read More